Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu

Study of PDR001 and/or MBG453 in Combination With Decitabine in Patients With AML or High Risk MDS

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT03066648
Recruitment Status : Recruiting
First Posted : February 28, 2017
Last Update Posted : March 11, 2021
Sponsor:
Information provided by (Responsible Party):
Novartis ( Novartis Pharmaceuticals )

No Study Results Posted on ClinicalTrials.gov for this Study
Recruitment Status : Recruiting
Estimated Primary Completion Date : November 1, 2021
Estimated Study Completion Date : November 1, 2021